Hai Zhu

BL-B01D1, a first-in-class EGFR–HER3 bispecific antibody–drug conjugate, in patients with locally advanced or metastatic solid tumours: a first-in-human, open-label, multicentre, phase 1 study

Yuxiang Ma, Yan Huang, Yuanyuan Zhao et al. · The Lancet Oncology · 2024 · 121 citations

Medicine, Oncology, Pharmacology +14

BL-B01D1, a first-in-class EGFRxHER3 bispecific antibody-drug conjugate (ADC), in patients with locally advanced or metastatic solid tumor: Results from a first-in-human phase 1 study.

Li Zhang, Yuxiang Ma, Yuanyuan Zhao et al. · Journal of Clinical Oncology · 2023 · 27 citations

Medicine, Oncology, Pharmacology +16

Aggressive crystalloid adversely affects outcomes in a pediatric trauma population

Hai Zhu, Bailin Chen, Chunbao Guo · European Journal of Trauma and Emergency Surgery · 2019 · 22 citations

Medicine, Child Health, Pediatrics +10

Prediction of perioperative outcome after hepatic resection for pediatric patients

Jianxia Liu, Yunfei Zhang, Hai Zhu et al. · BMC Gastroenterology · 2019 · 18 citations · Full text

Medicine, Pediatrics, Surgery +13

NF‐κB inactivation attenuates the M1 macrophage polarization in experimental necrotizing enterocolitis by glutaredoxin‐1 deficiency

Yang Luo, Dan Mo, Hongjie Guo et al. · Cell Biology International · 2022 · 17 citations

Life Sciences, Immunology, Pathology +17